New Initiative Launched to Combat Sickle Cell Disease Challenges Across Africa
In a significant move to strengthen healthcare for individuals with sickle cell disease across Africa, health leaders and their partners have unveiled the Imara Plan. This initiative aims to standardize care, ensuring that countries effectively translate their health policies into coordinated actions for screening, diagnosis, treatment, and lifelong management of sickle cell disease (SCD).
Sickle cell disease remains a formidable public health challenge in Africa, where it accounts for almost 80% of the global burden, resulting in hundreds of thousands of children being born with the condition each year. While awareness, screening, and access to treatment have improved, many patients still experience fragmented care, delayed diagnoses, and inadequate follow-up. The pressing issue is not a lack of knowledge but rather the need for a collective approach to healthcare.
The Imara Plan focuses on enabling African nations to articulate a systematic approach encompassing screening, diagnosis, treatment, specialist referrals, follow-up, and long-term care within a cohesive care continuum. Rather than duplicating existing global and regional initiatives, Imara seeks to complement these efforts by providing a practical framework for governments and partners to create a robust support system along the patient care pathway.
Dr. Chris Baryomunsi, Uganda's Minister of Health, emphasized the necessity for families to receive comprehensive support beyond initial diagnosis, highlighting the importance of regular treatment and medical follow-up close to their homes. Likewise, Dr. Ouma Oluga, Kenya’s Chief Secretary for Medical Services, remarked on the critical nature of early diagnosis and lifelong care for families affected by sickle cell disease. The integration of services via the social health authority strives to enhance access to necessary diagnostics, treatments, and safe blood, empowering a well-coordinated healthcare system that meets patients' lifelong needs.
The initial implementation phase of this plan is underway in Uganda, Kenya, and Ivory Coast, designed to be adaptable to national systems while targeting local needs with the ultimate goal of improving care continuity for individuals suffering from sickle cell disease. Mario Ottiglio, from the Global Sickle Cell Coalition, expressed support for initiatives aimed at fostering public commitment, aligning practices, and minimizing care fragmentation. He pointed out that the Imara plan provides a concrete action strategy to translate these commitments into easily accessible patient care.
Eyong Ebai, Director General for Africa at Terumo Blood and Cell Technologies, noted the substantial progress made in recognizing sickle cell disease as a public health priority. The next crucial step involves ensuring that these priorities lead to well-coordinated care pathways that accompany patients throughout their lives, aligning with the goals of the Imara Plan.
This initiative is part of broader efforts by African governments, the African Center for Disease Control and Prevention (Africa CDC), and the World Health Organization to enhance early diagnosis, strengthen health systems, and expand access to care for individuals affected by sickle cell disease. The Imara Plan aims to facilitate a shift from fragmented interventions to coordinated health systems, bringing together governments, clinicians, patient associations, blood transfusion services, and implementing partners to achieve streamlined care pathways across the continent.
This collaborative approach focuses on ten priority areas addressing primary, secondary, and tertiary care, helping countries to identify gaps, coordinate partner actions, and enhance the systems needed for consistent care.
For further information on Terumo Blood and Cell Technologies, visit their website. To learn more about the Global Sickle Cell Coalition, please access their online resources.
Sickle cell disease remains a formidable public health challenge in Africa, where it accounts for almost 80% of the global burden, resulting in hundreds of thousands of children being born with the condition each year. While awareness, screening, and access to treatment have improved, many patients still experience fragmented care, delayed diagnoses, and inadequate follow-up. The pressing issue is not a lack of knowledge but rather the need for a collective approach to healthcare.
The Imara Plan focuses on enabling African nations to articulate a systematic approach encompassing screening, diagnosis, treatment, specialist referrals, follow-up, and long-term care within a cohesive care continuum. Rather than duplicating existing global and regional initiatives, Imara seeks to complement these efforts by providing a practical framework for governments and partners to create a robust support system along the patient care pathway.
Dr. Chris Baryomunsi, Uganda's Minister of Health, emphasized the necessity for families to receive comprehensive support beyond initial diagnosis, highlighting the importance of regular treatment and medical follow-up close to their homes. Likewise, Dr. Ouma Oluga, Kenya’s Chief Secretary for Medical Services, remarked on the critical nature of early diagnosis and lifelong care for families affected by sickle cell disease. The integration of services via the social health authority strives to enhance access to necessary diagnostics, treatments, and safe blood, empowering a well-coordinated healthcare system that meets patients' lifelong needs.
The initial implementation phase of this plan is underway in Uganda, Kenya, and Ivory Coast, designed to be adaptable to national systems while targeting local needs with the ultimate goal of improving care continuity for individuals suffering from sickle cell disease. Mario Ottiglio, from the Global Sickle Cell Coalition, expressed support for initiatives aimed at fostering public commitment, aligning practices, and minimizing care fragmentation. He pointed out that the Imara plan provides a concrete action strategy to translate these commitments into easily accessible patient care.
Eyong Ebai, Director General for Africa at Terumo Blood and Cell Technologies, noted the substantial progress made in recognizing sickle cell disease as a public health priority. The next crucial step involves ensuring that these priorities lead to well-coordinated care pathways that accompany patients throughout their lives, aligning with the goals of the Imara Plan.
This initiative is part of broader efforts by African governments, the African Center for Disease Control and Prevention (Africa CDC), and the World Health Organization to enhance early diagnosis, strengthen health systems, and expand access to care for individuals affected by sickle cell disease. The Imara Plan aims to facilitate a shift from fragmented interventions to coordinated health systems, bringing together governments, clinicians, patient associations, blood transfusion services, and implementing partners to achieve streamlined care pathways across the continent.
This collaborative approach focuses on ten priority areas addressing primary, secondary, and tertiary care, helping countries to identify gaps, coordinate partner actions, and enhance the systems needed for consistent care.
For further information on Terumo Blood and Cell Technologies, visit their website. To learn more about the Global Sickle Cell Coalition, please access their online resources.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.